Collaboration results in platform to help researchers overcome challenges in MSC researchNextCell-Cord RUO cells designed for ...

Perfuse Therapeutics’ investigational lead program shows potential to become one of the first disease-modifying treatments for both Glaucoma and Diabetic Retinopathy (DR)High unmet medical need of ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical ...

The global immuno-oncology market is projected to grow at a robust CAGR of approximately 21% over the next five years. This strong expansion is fueled by the rising global cancer burden, continuous ...

LUND, SE / ACCESS Newswire / May 6, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - Spago Nanomedical AB (publ) announced today that the independent Data Monitoring Committee (DMC) of the Tumorad ...

VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F), a clinical-stage biopharmaceutical company that advances high-potential drug candidates ...

LUND, SE / ACCESS Newswire / May 6, 2026 / Alligator Bioscience (STO:ATORX)The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English ...

IntroductionThe global herbal medicinal products market is witnessing steady growth and is projected to expand at a compound annual growth rate (CAGR) of 5–8% during the forecast period. This growth ...

MSD (Merck) will acquire Terns Pharmaceuticals for approximately USD 6.7 billion, adding investigational leukemia therapy ...

Secures long‑term ownership and protection of Link_TSG6, strengthening its global IP position in key markets·         De‑risks development and enhances long‑term value, supporting advancement ...

Global Biosimulation Market OverviewThe global biosimulation market is experiencing rapid expansion and is expected to grow at a remarkable compound annual growth rate of 15–20% through 2028. This ...

LUND, SE / ACCESS Newswire / May 6, 2026 / Cantargia AB (publ) (Nasdaq Stockholm:CANTA) will publish the company's interim report for Q1 2026 on Tuesday, May 19, 2026, at 07:00 a.m. CEST.In ...